白介素15(IL15)重組蛋白
Recombinant Interleukin 15 (IL15)
- 編號RPA061Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞核, 分泌, 細(xì)胞質(zhì)
- 預(yù)測分子量14.2kDa
- 實(shí)際分子量18/16/14kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Trp50~Ser162 with N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)5.1
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1344 ¥ 3360 ¥ 6720 ¥ 20160 ¥ 50400
- 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA061Hu01 | 白介素15(IL15)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA061Hu01 | 白介素15(IL15)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA061Hu01 | 白介素15(IL15)多克隆抗體 | WB; IHC; ICC; IP. |
LAA061Hu71 | 白介素15(IL15)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
RAA061Hu21 | 白介素15(IL15)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
MAA061Hu21 | 白介素15(IL15)單克隆抗體 | WB |
MAA061Hu22 | 白介素15(IL15)單克隆抗體 | WB; IHC; ICC; IP. |
SEA061Hu | 白介素15(IL15)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA061Hu | 白介素15(IL15)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
IGA061Hu21 | 白介素15(IL15)人基因嵌入小鼠 | 動物實(shí)驗(yàn),陽性對照。 |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Endocrine | Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training [Pubmed: 24006180] |
Endocrine | Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype [Pubmed:25522723] |
Med Sci Moni | miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice [PubMed: 26087886] |
Exercise physiology | Effects of intrinsic aerobic capacity, aging and physical activity on interleukin-15 protein level in serum and skeletal muscle [Dspace: Handle] |
Biotechnology Letters | Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice [s10529-017-2342-1] |
Journal?of?Controlled?Release | Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy. [pubmed:28408199] |
留言咨詢